Lower Your Dose to Elevate Your Patient Care
There’s no shortage of dental technology within our reach that claims to be game changing, groundbreaking, and ready to transform our patient care in infinite ways. While it may be wise to take these claims with a grain (or a shaker) of salt, there are several digital tools that do live up to their hype, such as 3D CBCT imaging.
Introduced to the dental community in the early 2000s, cone beam imaging systems have had a profound impact on diagnosis, treatment planning, and clinical outcomes—not just for specialists and oral surgeons, but for general practitioners, too. The shift to 3D imaging also has ushered in a change in radiation dose—not unlike the switch from film to digital x-rays—in part due to imaging manufacturers like Planmeca that have been hard at work creating protocols to make acquiring 3D images for virtually every case scenario a no-brainer.
Leading the Low-Dose Imaging Charge
The dedicated folks who head up Planmeca’s research and development team created Planmeca Ultra Low Dose (ULD) technology, which produces a dramatically lower patient radiation dose without compromising image quality. In fact, in a recent clinical study conducted by the University of North Carolina at Chapel Hill School of Dentistry and the University of Helinski in Finland, an average reduction in dose of 77% was achieved using Planmeca ULD protocols compared to standard protocols. Amazingly, the study found that there was no statistical reduction in image quality between the Planmeca ULD and standard protocols.
In a nutshell, this means that clinicians can take a 3D image with the Planmeca ProMax 3D Mid using the same radiation levels as a traditional 2D x-ray.
Watch this quick video to find out more about Planmeca’s commitment to Ultra Low Dose technology.
This paves the way for practices to use 3D imaging on a more routine basis—for example, when evaluating new patients or treating those who present with pain or discomfort. For these cases in particular, the worst-case scenario for both patient and practitioner is an inconclusive diagnosis that forces the clinician to either put a watch on the area or refer the patient out to a specialist, where they will likely undergo more radiation.
“One of the reasons I purchased a Planmeca CBCT unit was the low dose technology,” shared Dr. Michael Young, a general practitioner in Michigan who has been using CBCT technology in his practice the past 5 years. “I called my rep and asked for the dose information on my Planmeca ProMax 3D Classic. What I learned really opened my eyes. By using Planmeca’s Ultra Low Dose technology, I can take a 5 x 5 limited view of the area of concern, which delivers the same or low patient radiation compared to the 2D periapical, and we can make an accurate diagnosis right away. This became my ‘3D PA,’ and I follow this imaging protocol when a patient comes in with discomfort. It’s been incredible.”
Early Diagnosis Elevates Patient Care
The shift from 2D to 3D periapical x-rays, in particular, has been transformative for Dr. Young—allowing him to make a much earlier diagnosis and provide treatment sooner, instead of sending the patient home and asking them to return if their symptoms worsen. This has inevitably led to less bony deconstruction and tooth loss for Dr. Young’s patients, while elevating the quality of care they receive in his hands.
“While most CBCT manufacturers tout low dose imaging, none can produce images like Planmeca,” Dr. Young concluded.
Click here to learn more about Planmeca Ultra Low Dose imaging protocol and how it can be a game-changer for general dentists.